Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform

Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has secured over $100 million in an oversubscribed Series B funding round.